Absolute quantification of myosin heavy chain isoforms by selected reaction monitoring can underscore skeletal muscle changes in a mouse model of amyotrophic lateral sclerosis

Analytical and Bioanalytical Chemistry

Volumn 409, Issue 8, 2017, Pages 2143-2153

  Peggion, Caterina ^a   Massimino, Maria Lina ^a   Biancotto, Giancarlo ^b   Angeletti, Roberto ^b   Reggiani, Carlo ^a   Sorgato, Maria Catia ^a   Bertoli, Alessandro ^a   Stella, Roberto ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

Author keywords

Absolute quantification; Amyotrophic lateral sclerosis; Myosin heavy chain; Selected reaction monitoring; Skeletal muscle; Targeted proteomics

Indexed keywords

CHAINS; DIAGNOSIS; MAMMALS; MASS SPECTROMETRY; MOLECULAR BIOLOGY; MUSCULOSKELETAL SYSTEM; NEURODEGENERATIVE DISEASES; PROTEINS;

ABSOLUTE QUANTIFICATION; AMYOTROPHIC LATERAL SCLEROSIS; MYOSIN HEAVY CHAIN; SELECTED REACTION MONITORING; SKELETAL MUSCLE; TARGETED PROTEOMICS;

MUSCLE;

MYOSIN HEAVY CHAIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; DISEASE MODEL; HUMAN; METABOLISM; MOUSE; PATHOLOGY; SKELETAL MUSCLE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MUSCLE, SKELETAL; MYOSIN HEAVY CHAINS;

EID: 85009286755     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-016-0160-2     Document Type: Article

References (54)

1. Dubowitz V, Pearse AG. Reciprocal relationship of phosphorylase and oxidative enzymes in skeletal muscle. Nature. 1960;185:701–2.
2. Edström L, Kugelberg E. Histochemical composition, distribution of fibres and fatiguability of single motor units. Anterior tibial muscle of the rat. J Neurol Neurosurg Psychiatry. 1968;31:424–33.
3. Stein JM, Padikula HA. Histochemical classification of individual skeletal muscle fibers of the rat. Am J Anat. 1962;110:103–23.
4. Brooke MH, Kaiser KK. Three “myosin adenosine triphosphatase” systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem. 1970;18:670–2.
5. Reggiani C, Bottinelli R, Stienen GJ. Sarcomeric myosin isoforms: fine tuning of a molecular motor. News Physiol Sci. 2000;15:26–33.
6. Pette D, Staron RS. Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol. 1990;116:1–76.
7. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev. 1996;76:371–423.
8. Rossi AC, Mammucari C, Argentini C, Reggiani C, Schiaffino S. Two novel/ancient myosins in mammalian skeletal muscles: MYH14/7b and MYH15 are expressed in extraocular muscles and muscle spindles. J Physiol. 2010;588:353–64.
9. Staron RS, Pette D. Correlation between myofibrillar ATPase activity and myosin heavy chain composition in rabbit muscle fibres. Histochemistry. 1986;86:19–23.
10. McLoon LK, Park HN, Kim JH, Pedrosa-Domellöf F, Thompson LV. A continuum of myofibers in adult rabbit extraocular muscle: force, shortening velocity, and patterns of myosin heavy chain colocalization. J Appl Physiol. 2011;111:1178–89.
11. Stephenson GM. Hybrid skeletal muscle fibres: a rare or common phenomenon? Clin Exp Pharmacol Physiol. 2001;28:692–702.
12. Harrison BC, Allen DL, Leinwand LA. IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men. Skelet Muscle. 2011;1:5.
13. Blaauw B, Schiaffino S, Reggiani C. Mechanisms modulating skeletal muscle phenotype. Compr Physiol. 2013;3:1645–87.
14. Webster C, Silberstein L, Hays AP, Blau HM. Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell. 1988;52:503–13.
15. Hegedus J, Putman CT, Tyreman N, Gordon T. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol. 2008;586:3337–51.
16. Dobrowolny G, Aucello M, Musarò A. Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation. Skelet Muscle. 2011;1:3.
17. Clarke NF. Congenital fiber-type disproportion. Semin Pediatr Neurol. 2011;18:264–71.
18. Tajsharghi H, Oldfors A. Myosinopathies: pathology and mechanisms. Acta Neuropathol. 2013;125:3–18.
19. Brooke MH, Kaiser KK. Three “myosin ATPase” systems. The nature of their pH liability and sulphydryl dependence. J Histochem Cytochem. 1970;18:670–2.
20. Khan MA. Histochemical sub-types of three fibre-types of avian skeletal muscle. Histochemistry. 1976;50:9–16.
21. Staron RS, Hikida RS. Histochemical, biochemical, and ultrastructural analyses of single human muscle fibers, with special reference to the C-fiber population. J Histochem Cytochem. 1982;40:563–8.
22. Schiaffino S, Gorza L, Sartore S, Saggin L, Ausoni S, Vianello M, et al. Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J Muscle Res Cell Motil. 1989;10:197–205.
23. Talmadge RJ, Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol. 1993;75:2337–40.
24. Bamman MM, Clarke MS, Talmadge RJ, Feeback DL. Enhanced protein electrophoresis technique for separating human skeletal muscle myosin heavy chain isoforms. Electrophoresis. 1999;20:466–8.
25. Blough ER, Rennie ER, Zhang F, Reiser PJ. Enhanced electrophoretic separation and resolution of myosin heavy chains in mammalian and avian skeletal muscles. Anal Biochem. 1996;233:31–5.
26. Sant’Ana Pereira JA, Greaser M, Moss RL. Pulse electrophoresis of muscle myosin heavy chains in sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem. 2001;291:229–36.
27. Picard B, Barboiron C, Chadeyron D, Jurie C. Protocol for high-resolution electrophoresis separation of myosin heavy chain isoforms in bovine skeletal muscle. Electrophoresis. 2011;32:1804–6.
28. Mizunoya W, Wakamatsu J, Tatsumi R, Ikeuchi Y. Protocol for high-resolution separation of rodent myosin heavy chain isoforms in a mini-gel electrophoresis system. Anal Biochem. 2008;377:111–3.
29. Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci. 2001;2:806–19.
30. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med. 2001;344:1688–700.
31. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
32. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772–5.
33. Ferri A, Nencini M, Casciati A, Cozzolino M, Angelini DF, Longone P, et al. Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells. FASEB J. 2004;18:1261–3.
34. Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet. 2010;19:2284–302.
35. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425–36.
36. Pansarasa O, Rossi D, Berardinelli A, Cereda C. Amyotrophic lateral sclerosis and skeletal muscle: an update. Mol Neurobiol. 2014;49:984–90.
37. Stella R, Massimino ML, Sandri M, Sorgato MC, Bertoli A. Cellular prion protein promotes regeneration of adult muscle tissue. Mol Cell Biol. 2010;30:4864–76.
38. Massimino ML, Peggion C, Loro F, Stella R, Megighian A, Scorzeto M, et al. Age-dependent neuromuscular impairment in prion protein knock-out mice. Muscle Nerve. 2016;53:269–79.
39. Switzer RC, Merril CR, Shifrin S. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem. 1979;98:231–7.
40. Wiśniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6:359–62.
41. Kirkpatrick DS, Gerber SA, Gygi SP. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods. 2005;35:265–73.
42. MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966–8.
43. Karlsson C, Malmström L, Aebersold R, Malmström J. Proteome-wide selected reaction monitoring assays for the human pathogen Streptococcus pyogenes. Nat Commun. 2012;3:1301.
44. Picotti P, Rinner O, Stallmach R, Dautel F, Farrah T, Domon B, et al. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat Methods. 2010;7:43–6.
45. Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, White FM. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signalling networks. Proc Natl Acad Sci U S A. 2007;104:5860–5.
46. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008;4:222.
47. Mallick P, Schirle M, Chen SS, Flory MR, Lee H, Martin D, et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nat Biotechnol. 2007;25:125–31.
48. Holman SW, Sims PF, Eyers CE. The use of selected reaction monitoring in quantitative proteomics. Bioanalysis. 2012;4:1763–8.
49. Murgia M, Nagaraj N, Deshmukh AS, Zeiler M, Cancellara P, Moretti I, et al. Single muscle fiber proteomics reveals unexpected mitochondrial specialization. EMBO Rep. 2015;16:387–95.
50. Hughes SM, Taylor JM, Tapscott SJ, Gurley CM, Carter WJ, Peterson CA. Selective accumulation of MyoD and myogenin mRNAs in fast and slow adult skeletal muscle is controlled by innervation and hormones. Development. 1993;118:1137–47.
51. Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012;9:555–66.
52. Hegedus J, Putman CT, Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2007;28:154–64.
53. Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9:408–19.
54. Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros-Louis F, et al. Neuroprotection through excitability and mTOR required in ALS motoneurons to delay disease and extend survival. Neuron. 2013;80:80–96.